Lack of a significant role of P-Rex1, a major regulator of macrophage Rac1 activation and chemotaxis, in atherogenesis

被引:10
作者
Wang, Zhenglong [1 ,2 ]
Dong, Xuemei [1 ,2 ]
Li, Zhong [3 ]
Smith, Jonathan D. [4 ]
Wu, Dianqing [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[3] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA
[4] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA
关键词
P-Rex1; Rac1; GEF; Chemotaxis; Atherosclerosis;
D O I
10.1016/j.prostaglandins.2008.04.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Rho GTPases are known to play important role in regulating multiple cellular processes that include cell polarization and migration. Among these Rho GTPases, Rac has been shown to be essential for F actin formation and cell migration. P-Rex1 is a guanine nucleotide exchange factor (GEF) that was previously found to mediate the activation of Rac2, but not Rac1, in mouse neutrophils. Objectives: Here we examined the role of P-Rex1 in mouse macrophages and antherogenesis. Methods and results: PBD (p21 binding domain) pull down assay was performed to compare the Rac1 activation in WT and P-Rex1-deficient macrophage. We found that P-Rex1 is a major Rac1 regulator in mouse macrophages as its deficiency significantly compromises macrophage chemotaxis, superoxide production (SOD), and Rac1 activation in response to chemoattractants. The potential role of P-Rex1 in atherogenesis is also investigated by transferring P-Rex1-deficient bone marrow cells to LDLR deficient mice. Contrary to our prediction, P-Rex1 deficiency did not alter atherogenesis, suggesting chemoattractant-induced macrophage migration may not have a significant role in atherogenesis. Conclusions: P-Rex1 is one of the major GEFs in macrophage regulating Rac1 activation and chemotaxis. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:9 / 13
页数:5
相关论文
共 25 条
[1]  
Baglione Julie, 2006, V129, P83
[2]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[3]   Rho activation at a glance [J].
Buchsbaum, Rachel J. .
JOURNAL OF CELL SCIENCE, 2007, 120 (07) :1149-1152
[4]   Rho and Rac take center stage [J].
Burridge, K ;
Wennerberg, K .
CELL, 2004, 116 (02) :167-179
[5]  
Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205
[6]   P-Rex2, a new guanine-nucleotide exchange factor for Rac [J].
Donald, S ;
Hill, K ;
Lecureuil, C ;
Barnouin, R ;
Krugmann, S ;
Coadwell, WJ ;
Andrews, SR ;
Walker, SA ;
Hawkins, PT ;
Stephens, LR ;
Welch, HCE .
FEBS LETTERS, 2004, 572 (1-3) :172-176
[7]   P-Rex1 is a primary Rac2 guanine nucleotide exchange factor in mouse neutrophils [J].
Dong, XM ;
Mo, ZC ;
Bokoch, G ;
Guo, CY ;
Li, Z ;
Wu, DQ .
CURRENT BIOLOGY, 2005, 15 (20) :1874-1879
[8]   Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation [J].
Doody, GM ;
Bell, SE ;
Vigorito, E ;
Clayton, E ;
McAdam, S ;
Tooze, R ;
Fernandes, C ;
Lee, IJ ;
Turner, M .
NATURE IMMUNOLOGY, 2001, 2 (06) :542-547
[9]   Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells [J].
Fujikawa, K ;
Miletic, AV ;
Alt, FW ;
Faccio, R ;
Brown, T ;
Hoog, J ;
Fredericks, J ;
Nishi, S ;
Mildiner, S ;
Moores, SL ;
Brugge, J ;
Rosen, FS ;
Swat, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (10) :1595-1608
[10]   Catching a GEF by its tail [J].
Garcia-Mata, Rafael ;
Burridge, Keith .
TRENDS IN CELL BIOLOGY, 2007, 17 (01) :36-43